Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 1-10 of 34

Page
per page
  1. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     19 Citation
    Target: ROCK
    Summary: ROCK1 inhibitor
      ≥111.2 mg/mL
  2. 740 Y-P
    B5246 740 Y-P
     5 Citation
    Target: PI3K
    Summary: PI 3-kinase activator,cell permeable
      ≥163.54 mg/mL
  3. SBE 13 HCl
    B5857 SBE 13 HCl
    Target: PLK
    Summary: Inactive Plk1 inhibitor
      Soluble in DMSO
  4. Peptide YY(3-36), PYY, human
    A1115 Peptide YY(3-36), PYY, human
    Target: NPY Receptors
    Summary: Y2R agonist
      ≥405 mg/mL
  5. BMS-378806
    B1533 BMS-378806
     1 Citation
    Target: gp120/CD4
    Summary: Gp120/CD4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.2 mg/mL
  6. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     21 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  7. MLN8054
    A4114 MLN8054
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      insoluble in EtOH; insoluble in H2O; ≥39.05 mg/mL
  8. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  9. Lithium carbonate
    B7705 Lithium carbonate
    Target: Na /K ATPases
    Summary: Na+/K+ ATPase pump inhibitor
      insoluble in EtOH; ≥2.74 mg/mL
  10. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective

Items 1-10 of 34

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 1 item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 3item
  4. Raf 2item
  5. Aurora Kinases 1 item
  6. mTOR 2item
  7. MMP 2item
  8. Androgen Receptors 1 item
  9. FLT3 1 item
  10. P-glycoprotein (P-gp) 1 item
  11. PLK 1 item
  12. Eph Receptors 1 item
  13. VEGFR 4item
  14. PDGFR 4item
  15. c-Kit 2item
  16. RET 1 item
  17. Phosphodiesterases (PDEs) 1 item
  18. Bcr-Abl 1 item
  19. FGFR 2item
  20. Voltage-gated Sodium (NaV) Channels 1 item
  21. Src 1 item
  22. ROCK 1 item
  23. DNA-PK 2item
  24. HSP90 1 item
  25. LRRK2 1 item
  26. Glutamate (Metabotropic) Group I Receptors 1 item
  27. NPY Receptors 1 item
  28. Na /K ATPases 1 item
  29. P110 1 item
  30. Hck 1 item
  31. Catechol O-Methyltransferase (COMT) 1 item
  32. angiogenesis 1 item
  33. Histone Acetyltransferases (HATs) 1 item
  34. NOD1 1 item
  35. DCLK2 1 item
  36. gp120/CD4 1 item
  37. ATM 1 item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 17item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 1 item
  11. Colorectal Cancer 3item
  12. Glioblastoma 2item
  13. Glioma 2item
  14. HIV 1 item
  15. Lung Cancer 1 item
  16. Lymphoma 1 item
  17. Multiple Myeloma 3item
  18. Myelofibrosis 1 item
  19. Neuroblastoma 3item
  20. Neurocognitive Disorders 1 item
  21. Non-small Cell Lung Carcinoma 1 item
  22. Obsessive-Compulsive Disorder 1 item
  23. Osteoporosis 1 item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 1 item
  26. Prostate Cancer 2item
  27. Pulmonary Fibrosis 1 item
  28. Renal Cancer 1 item
  29. Schizophrenia 1 item
  30. Soft Tissue Sarcoma 1 item
  31. Thyroid Cancer 1 item